UHMS Accreditation for Wound Care: Standards & Measures

UHMS Accreditation for Wound Care and Hyperbaric Programs: What the Standards Actually Require

UHMS accreditation is the credential-body standard most wound centers with hyperbaric services measure themselves against. Unlike hospital accreditation, where a program assembles its own measure set, UHMS is built around a published, externally defined set of requirements covering personnel credentialing, facility safety, and clinical quality demonstration — and programs preparing for it fail differently: not because they lack a measure framework, but because the personnel, chamber-safety, and data-submission requirements are more prescriptive than most applicants expect.

This reference breaks the UHMS Clinical Hyperbaric Facility Accreditation Program into its three working layers — credentialing, facility safety, and quality demonstration — and shows where the hyperbaric literature defines the outcome anchors a program should document. The pattern to keep in view: reviewers evaluate whether your operation matches a national standard, so the strongest evidence in the file is data comparable to everyone else's.

Layer 1 — Personnel Credentialing: The Standard That Surprises Applicants

The UHMS model is physician-credentialing-first. Hyperbaric medicine has been formally characterized as a high-risk procedure environment requiring specific privileged training — UHMS-aligned position papers laid out the credentialing framework that evolved into today's requirements: documented hyperbaric-specific physician training, a designated hyperbaric safety director, and credentialed inside attendings and chamber operators rather than general nursing staff covering the chamber ad hoc (PMID 17004418; PMID 17274317).

What that means operationally for a wound program:

- Physician hyperbaric privileges must be granted by your own institution's credentialing committee, based on documented training and case experience — UHMS accreditation does not substitute for local privileging; it verifies that local privileging was done to standard. - A named Safety Director with defined authority over chamber operations, emergency procedures, and staff training records. This is a role surveyors check by name and by training file, not a title on the org chart. - Chamber team competency documentation — inside tenders, operators, and divers-in-support roles need current training records, fire-safety drills, and equipment in-service documentation on file.

The layer-1 failure mode is drift: privileges granted correctly at program launch, then allowed to lapse during staff turnover. Surveyors sample credential files the way an auditor samples invoices — the lapse found in one file raises the question for all of them.

Layer 2 — Facility and Chamber Safety Standards

The facility layer covers chamber classification, fire-safety systems, electrical safety in the hyperbaric environment, and equipment maintenance documentation. Two points from the UHMS position literature matter for planning:

- UHMS has taken explicit positions on chamber technology boundaries — most visibly the position statement on low-pressure fabric (soft-sided) chambers, which are not acceptable for the clinical applications standard wound programs pursue (PMID 30241130). Programs budgeting for accreditation should plan around fixed, rigid multiplace or monoplace chambers meeting NFPA 99 Chapter 14 requirements, verifying the current edition against UHMS materials. - The accreditation program itself recognizes sustained performance: the "accreditation with distinction" tier exists for facilities demonstrating exemplary compliance histories and quality programs over successive cycles (PMID 18551795). That tier signals that UHMS evaluates programs longitudinally — a re-accreditation survey is materially different from a first survey because the prior cycle's findings follow the program.

Layer 3 — Demonstrating Quality: The HBOT Registry Path

The quality layer is where UHMS accreditation differs most from generic wound-center credentialing, and where the strongest published model exists. The UHMS Hyperbaric Oxygen Therapy Registry was built to let programs demonstrate quality and compliance through pooled, risk-stratified national data rather than self-reported local numbers — it records treatment indications, outcomes, and adverse events across contributing facilities, and participation gives a program benchmarkable HBOT outcome data for the accreditation file (PMID 29571226). The design principle is the one accreditation reviewers trust most: your data is credible because it is comparable to everyone else's.

The clinical outcome anchors behind that data are the hyperbaric literature itself. For the diabetic foot ulcer indication — the highest-volume wound-care HBOT use — systematic reviews and meta-analyses of randomized trials report improved major amputation rates and wound-healing outcomes with adjunctive hyperbaric oxygen therapy in hard-to-heal DFUs, with consistent direction across pooled analyses (PMID 34236155; PMID 28935291). A program's documentation should mirror the trial structure those reviews pool: defined wound population, fixed treatment course, binary dated healing and amputation endpoints, and adverse-event capture — the record shape both the registry and the survey process reward.

How the Three Layers Map to a Survey File

| Layer | Core requirement | Common deficiency pattern | |---|---|---| | Personnel credentialing | Hyperbaric-specific physician privileges, named Safety Director, chamber team competency files | Lapsed privileges and stale training records after staff turnover | | Facility safety | Fixed rigid chamber to NFPA 99 Ch. 14, fire/electrical safety systems, maintenance documentation | Incomplete drill logs; equipment service records not retained per cycle | | Quality demonstration | Registry participation (HBOT Registry) or equivalent longitudinal outcome data with risk adjustment | Self-reported local numbers with no denominator definitions or benchmarks |

Where Biologics Documentation Intersects UHMS Accreditation

UHMS accreditation evaluates the hyperbaric service, not which dressings or allografts the wound clinic stocks — the same separation that applies in Joint Commission surveys. The intersection is documentation discipline: advanced biologic therapies such as amniotic membrane allografts enter the accreditation file only through the wound center's standard selection criteria, healing-trajectory tracking, and escalation rules for biologic-eligible wounds. Programs that document biologic use with trial-grade endpoints — population defined, interval fixed, healing binary and dated — produce records that satisfy both the wound-quality file and the hyperbaric quality file without duplicate work. Our broader operations guide covers how those outcome files feed accreditation and value analysis dossiers (wound care accreditation quality metrics), and the Joint Commission measures reference maps the hospital-side channel (Joint Commission wound care performance measures).

Frequently Asked Questions

UHMS accreditation is the Undersea and Hyperbaric Medical Society's Clinical Hyperbaric Facility Accreditation Program — a voluntary, externally defined credential covering personnel credentialing, chamber and facility safety, and clinical quality demonstration for programs providing hyperbaric oxygen therapy, including most wound centers with HBOT services.

Three layers: hyperbaric-specific physician credentialing through local privileging plus a named Safety Director and documented chamber-team training (PMID 17004418; PMID 17274317); a fixed rigid chamber meeting NFPA 99 Chapter 14 fire and electrical safety requirements — low-pressure fabric chambers are excluded by UHMS position (PMID 30241130); and demonstrated quality through longitudinal, benchmarkable outcome data, for which the UHMS Hyperbaric Oxygen Therapy Registry is the published model (PMID 29571226). Verify specifics against official UHMS materials for your program type.

Accreditation cycles run in multi-year terms, with re-accreditation surveys evaluating the compliance history since the prior cycle; sustained exemplary programs can qualify for the "accreditation with distinction" tier (PMID 18551795). Most programs budget several months of preparation for a first survey, concentrated on credentialing files and quality-data infrastructure.

Registry participation is the strongest documented pathway for demonstrating clinical quality and compliance because it provides pooled, risk-stratified national benchmark data rather than self-reported local numbers (PMID 29571226). Verify current requirements against the official UHMS accreditation program materials for your program type and cycle.

Mirror the controlled-trial structure the evidence base is built on: a defined wound population, a fixed treatment course, binary dated healing and amputation endpoints, and adverse-event capture. In diabetic foot ulcer populations, randomized-trial meta-analyses report improved amputation and healing outcomes with adjunctive HBOT (PMID 34236155; PMID 28935291), and those are the endpoint shapes reviewers and the registry recognize.

References

- PMID 29571226 — Fife CE, Eckert KA. "The Hyperbaric Oxygen Therapy Registry: Driving quality and demonstrating compliance." Undersea Hyperb Med, 2018. https://pubmed.ncbi.nlm.nih.gov/29571226/ - PMID 18551795 — "Clinical hyperbaric facility accreditation program's achieving accreditation 'with distinction'." Undersea Hyperb Med, 2008. https://pubmed.ncbi.nlm.nih.gov/18551795/ - PMID 17004418 — Workman WT. "Hyperbaric oxygen therapy: a high-risk procedure? An update." Undersea Hyperb Med, 2006. https://pubmed.ncbi.nlm.nih.gov/17004418/ - PMID 17274317 — Workman T. "Hyperbaric oxygen therapy: a high-risk procedure? An update II." Undersea Hyperb Med, 2006. https://pubmed.ncbi.nlm.nih.gov/17274317/ - PMID 30241130 — "UHMS Position Statement in full: low-pressure fabric hyperbaric chambers." Undersea Hyperb Med, 2018. https://pubmed.ncbi.nlm.nih.gov/30241130/ - PMID 34236155 — Moreira DA Cruz DL et al. "The role of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers: a systematic review with meta-analysis of randomized controlled trials on limb amputation and ulcer healing." Int Angiol, 2022. https://pubmed.ncbi.nlm.nih.gov/34236155/ - PMID 28935291 — Zhao D et al. "Efficacy and Safety of Hyperbaric Oxygen Therapy Used in Patients With Diabetic Foot: A Meta-analysis of Randomized Clinical Trials." Clin Ther, 2017. https://pubmed.ncbi.nlm.nih.gov/28935291/

Disclaimer: UHMS accreditation requirements vary by program edition, program type, and survey cycle; this article is educational guidance for clinicians and quality staff, not UHMS policy or a guarantee of survey outcomes. NextGen Biologics is not affiliated with or endorsed by UHMS. NextGen Biologics distributes amniotic membrane allografts; clinical claims are limited to cited published evidence.